Posted by Michael Wonder on 11 Mar 2021
Berlin Heals receives breakthrough device designation from FDA for its C-MIC heart failure device and initiates early feasibility study in the United States
11 March 2021 - Berlin Heals announced today that the US FDA has granted a breakthrough device designation for its proprietary Cardiac microcurrent therapy device.
The cardiac microcurrent therapy device is an implantable device that delivers a constant but minimal electrical DC current to the heart via two electrodes.
